NeoLight

Focus: NeoLight develops phototherapy devices, specifically phototherapy mattresses and beds, for treating neonatal jaundice (hyperbilirubinemia). The company operates as a specialized medical device/biotech firm focused on a narrow but clinically important neonatal care segment.

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About NeoLight

AI assessmentNot Hiring

No open roles listed right now. Follow NeoLight to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

2 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Key Products

Neolight Phototherapy Mattress

Hyperbilirubinemia, Neonatal

Pre-Commercial

Primary product candidate for treating elevated bilirubin in newborns; currently in early-stage clinical evaluation.

Skylife

Jaundice, Neonatal

Pre-Commercial

Help build intelligence for NeoLight

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Early-stage company in a niche therapeutic area (neonatal jaundice) with unmet clinical needs and limited competition
Opportunity to work on innovative phototherapy device technology with direct clinical impact on patient outcomes
Ground-floor opportunity at a focused biotech where individual contributions shape company trajectory

Watch Out For

Pre-revenue stage with no publicly available financial data limits transparency on runway, funding status, and salary competitiveness
Zero active job openings at time of analysis suggests minimal hiring activity and potential resource constraints
Limited clinical validation data (only 2 trials on record) and lack of publications indicate early development stage with uncertain regulatory pathway

Generated by Claude from NeoLight's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Secondary phototherapy bed platform targeting the same neonatal jaundice market as the mattress product.

Pipeline & Clinical Trials

Neolight Phototherapy Mattress

Hyperbilirubinemia, Neonatal

N/A

Clinical Trials (1)

NCT03723005A Light Emitting Diode (LED) Mattress for Phototherapy of Jaundiced Newborns

N/A

Skylife

Jaundice, Neonatal

N/A

Clinical Trials (1)

NCT03599258Comparison of Phototherapy Using Neolight Skylife Versus Standardized Phototherapy for Hyperbilirubinemia in Newborns

N/A

Open Jobs (0)

No open positions listed yet. Check their careers page directly.

Interview Prep Quick Facts

Portfolio: 2 clinical trials

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo